BIOMAT Database Logo BIOMAT Database Logo

Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats. 1996

M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Department of Pharmacology and Toxicology, Robert C. Byrd Health Sciences Center of West Virginia University, Morgantown, 26506-9223, USA.

The effect of the induction of pulmonary phospholipidosis by amiodarone on selected pulmonary host defense functions was studied in male Fischer-344 rats. One week of daily amiodarone treatment resulted in a 4.5-fold increase in total phospholipid in alveolar macrophages recovered from the lungs by bronchoalveolar lavage. The presence of the phospholipidosis had no effect on the phagocytosis of heat-killed yeast cells, the induction of luminol-dependent chemiluminescence, or the spontaneous release of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), or spontaneous and LPS-stimulated release of IL-1 by alveolar macrophages in vitro. In contrast, the LPS-stimulated release of IL-6 and TNF-alpha by phospholipidotic alveolar macrophages was enhanced compared with control cells. The pulmonary clearance of Listeria monocytogenes following intratracheal administration of the bacteria was not affected by the phospholipidotic condition. It appears that, in the context of the functions studied, the induction of pulmonary phospholipidosis by amiodarone does not impair pulmonary host defense processes in rats, and may actually be associated with the augmentation of some activities.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008064 Lipidoses Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved. Lipidosis,Lipoidosis
D008088 Listeriosis Infections with bacteria of the genus LISTERIA. Listeria Infections,Infections, Listeria,Infection, Listeria,Listeria Infection,Listerioses
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011650 Pulmonary Alveoli Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer

Related Publications

M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Effects of drug-induced pulmonary phospholipidosis on lung mechanics in rats.
May 1989, Journal of applied physiology (Bethesda, Md. : 1985),
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Chlorcyclizine--induced pulmonary phospholipidosis in rats.
November 1982, Research communications in chemical pathology and pharmacology,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
October 1989, The Journal of pharmacology and experimental therapeutics,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Host defense functions of pulmonary surfactant.
January 2004, Biology of the neonate,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats.
August 2003, Toxicology,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Amiodarone-induced phospholipidosis in rat alveolar macrophages.
March 1988, The American review of respiratory disease,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone.
October 1987, Biochemical pharmacology,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
October 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Tobacco smoke. Effects on pulmonary host defense.
July 1979, Inflammation,
M J Reasor, and C M McCloud, and M DiMatteo, and R Schafer, and A Ima, and I Lemaire
Chlorphentermine-induced neonatal and maternal pulmonary phospholipidosis in rats.
June 1983, Experimental and molecular pathology,
Copied contents to your clipboard!